MPR Weekly Dose 106 - FDA Approves COVID-19 Vaccine; EUA Submission for Kids Under 5; COVID Tests Recalled; Vupanorsen Development Ends; Cabenuva Approval Expanded

<p><span style="font-weight: 400;">This week: The approval of a second COVID-19 vaccine; Pfizer and BioNTech submit for Emergency use of their vaccine for children under 5; Pfizer have also stopped development on a potential drug treatment to reduce cardiovascular risk and severe hypertriglyceridemia; And new dosing options for a HIV drug.<br /></span></p>